Mankind Pharma Stock

Mankind Pharma P/B

The P/B (Price-to-Book Ratio) of Mankind Pharma (MANKIND.NS) as of Aug 19, 2026 is 6.00. In the previous year, P/B (Price-to-Book Ratio) was 9.18 — a change of -34.67% (lower).

P/B

6.00

YoY

-34.67%

Last updated:

P/B (Price-to-Book Ratio) of Mankind Pharma is 2026 6.00 . P/B (Price-to-Book Ratio) of Mankind Pharma was 2025 9.18 . It decreases by -34.67% lower compared to the previous year.
Access this data via the Eulerpool API

Mankind Pharma Stock analysis

What does Mankind Pharma do? Mankind Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mankind Pharma stock

P/B (Price-to-Book Ratio) of Mankind Pharma is 6.00 in 2026.

P/B (Price-to-Book Ratio) of Mankind Pharma changed from 9.18 to 6.00, representing a -34.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Mankind Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Mankind Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Mankind Pharma

All Key Metrics — Mankind Pharma